Psychedelic Medicine’s Rise in 2019

Late March of 2019, a collection of European technology investors made waves in the psychedelic medicine industry, amassing the largest-ever private financing round for biotech company, ATAI Life Sciences (“ATAI”). According to ATAI’s press release, the German-based company’s Series B financing … Read more about Psychedelic Medicine’s Rise in 2019

Iowa Bill to Legalize Psilocybin Mushrooms and MDMA

In a surprising move late last week, Iowa Rep. Jeff Shipley (R) filed two pieces of legislation in the Iowa state legislature to legalize specific psychedelic substances as treatments. The first bill would approve the medical use of psilocybin, methylenedioxymethamphetamine (“MDMA”), and ibogaine – … Read more about Iowa Bill to Legalize Psilocybin Mushrooms and MDMA